<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03546010</url>
  </required_header>
  <id_info>
    <org_study_id>38RC14.100</org_study_id>
    <nct_id>NCT03546010</nct_id>
  </id_info>
  <brief_title>Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition</brief_title>
  <acronym>TDAH</acronym>
  <official_title>Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyse thanks to eye tracking experiments ocular movement
      classical parameters in children with attention deficit hyperactivity (ADH) and to compare
      them to results obtained in healthy children and to results obtained with neuropsychological
      tests commonly used in standard health care.

      We should then be able to compare eye tracking with neuropsychological parameters.

      The final objective is to give to health professional a tool for ADH investigation with which
      they should be able to do a simple and effective follow up of children with ADH.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 5, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between oculometric and neuropsychological tests in ADH evaluation</measure>
    <time_frame>Day 1</time_frame>
    <description>Differentiation between simple oculomotor disorder and attentional-visual disorder</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Attention Deficit-Hyperactivity</condition>
  <arm_group>
    <arm_group_label>Oculometric and neuropsychological tests</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oculometric tests and neuropsychological tests</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychological tests</intervention_name>
    <description>WISC test, BRIEF test, NEPSY-2 test, TAP2.3 test, Teach test</description>
    <arm_group_label>Oculometric and neuropsychological tests</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Oculometric tests</intervention_name>
    <description>When the subject see a peripheric target, he should take a look not at the target but in the controlateral half-field, at a mirror position. This is called an anti-saccade task.</description>
    <arm_group_label>Oculometric and neuropsychological tests</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children between 8 and 12 years old

          -  Boys and girls

          -  DSM-IV-TR diagnostic criteria for ADH

          -  Children with methylprednisone treatment

          -  Social security affiliation

          -  signed informed consent

        Exclusion Criteria:

          -  specialised scholarship

          -  refusal from children or parents

          -  too law results in WISC test (pre-inclusion test)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annie Laurent, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grenoble Alps University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annie Laurent, MD</last_name>
    <phone>04 76 76 54 19</phone>
    <email>AnnieLaurent@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nathalie Guyader, MCD UJF</last_name>
    <phone>04 76 57 43 72</phone>
    <email>nathalie.guyader@gipsa-lab.grenoble-inp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grenoble Alps Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Laurent, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Malsert J, Guyader N, Chauvin A, Polosan M, Szekely D, Bougerol T, Marendaz C. Saccadic performance and cortical excitability as trait-markers and state-markers in rapid cycling bipolar disorder: a two-case follow-up study. Front Psychiatry. 2013 Jan 4;3:112. doi: 10.3389/fpsyt.2012.00112. eCollection 2012.</citation>
    <PMID>23293609</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 18, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <last_update_submitted>June 4, 2018</last_update_submitted>
  <last_update_submitted_qc>June 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

